ZURICH (Reuters) - Swiss drugmaker Novartis said on Tuesday it would exchange certain assets with GlaxoSmithKline and divest its animal health business to Eli Lilly.
NOVARTIS (NOVN.CH)said it had agreed to acquire GSK's oncology products for a $14.5 billion payment. The Swiss drugmaker said it would divest its vaccines business, excluding flu, to GSK for $7.1 billion plus royalties.
In a separate transaction, Novartis said it had agreed to divest its animal health division to Eli Lilly for approximately $5.4 billion.
(Reporting by Alice Baghdjian; Editing by Erica Billingham)
(This story corrects $7.1 million to $7.1 billion in the second paragraph)
